Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer risk with methotrexate-TNF antagonist combination therapy compared to TNF-antagonist monotherapy in IBD.

Inflammatory bowel diseases·2026
Same author

Toward Artificial Intelligence-driven Clinical Decision Support Tools in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same author

Statistics and AI - A Fireside Conversation.

Harvard data science review·2026
Same author

Design and Analysis of Randomized Clinical Trials With Average Hazard: Practical Guidance and Tools for Implementation.

Statistics in medicine·2026
Same author

Predicting the timing of first sustained cognitive worsening in Alzheimer's disease using real-world clinical data and machine learning.

medRxiv : the preprint server for health sciences·2026
Same author

Nonparametric estimation of the total treatment effect with multiple outcomes in the presence of terminal events.

Biometrics·2026

Related Experiment Video

Updated: Sep 27, 2025

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

37.1K

Robust approach to combining multiple markers to improve surrogacy.

Xuan Wang1, Layla Parast2, Larry Han1

  • 1Department of Biostatistics, Harvard University, Boston, Massachusetts, USA.

Biometrics
|April 15, 2022
PubMed
Summary

This study introduces a new method to combine multiple surrogate markers for clinical trials, improving efficiency and reducing costs. The calibrated model fusion approach enhances the accuracy of predicting long-term treatment outcomes using short-term markers.

Keywords:
multiple surrogate markersnonparametric estimationproportion of treatment effect explained

More Related Videos

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities
07:13

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities

Published on: October 27, 2023

1.4K
In Utero Electroporation of Multiaddressable Genome-Integrating Color MAGIC Markers to Individualize Cortical Mouse Astrocytes
06:47

In Utero Electroporation of Multiaddressable Genome-Integrating Color MAGIC Markers to Individualize Cortical Mouse Astrocytes

Published on: May 21, 2020

5.7K

Related Experiment Videos

Last Updated: Sep 27, 2025

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

37.1K
Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities
07:13

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities

Published on: October 27, 2023

1.4K
In Utero Electroporation of Multiaddressable Genome-Integrating Color MAGIC Markers to Individualize Cortical Mouse Astrocytes
06:47

In Utero Electroporation of Multiaddressable Genome-Integrating Color MAGIC Markers to Individualize Cortical Mouse Astrocytes

Published on: May 21, 2020

5.7K

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Medical Informatics

Background:

  • Clinical trials often rely on long-term outcomes, increasing duration and cost.
  • Effective surrogate markers can predict treatment effects on long-term outcomes, improving trial efficiency.
  • Existing methods for combining multiple surrogate markers are limited.

Purpose of the Study:

  • To develop a novel calibrated model fusion approach for optimally combining multiple surrogate markers.
  • To enhance the accuracy and validity of composite surrogate markers in clinical trials.
  • To improve the prediction of treatment effects on long-term outcomes.

Main Methods:

  • Building on the optimal transformation framework, a calibrated model fusion approach is proposed.
  • Two initial estimates of optimal composite scores are obtained using different modeling strategies.
  • An optimal calibrated combination of these scores is estimated to ensure validity and optimality.

Main Results:

  • The proposed method optimally combines multiple markers to improve surrogacy without strict parametric assumptions.
  • The approach avoids the curse of dimensionality associated with fully nonparametric methods.
  • Theoretical properties are derived, and simulation studies demonstrate finite sample performance.

Conclusions:

  • The calibrated model fusion approach offers a unique and effective way to combine multiple surrogate markers.
  • This method enhances the efficiency of clinical trials by improving the prediction of long-term outcomes.
  • The approach was illustrated using data from the Diabetes Prevention Program study.